HUE053947T2 - Injektálható bioanyagok - Google Patents

Injektálható bioanyagok

Info

Publication number
HUE053947T2
HUE053947T2 HUE19182834A HUE19182834A HUE053947T2 HU E053947 T2 HUE053947 T2 HU E053947T2 HU E19182834 A HUE19182834 A HU E19182834A HU E19182834 A HUE19182834 A HU E19182834A HU E053947 T2 HUE053947 T2 HU E053947T2
Authority
HU
Hungary
Prior art keywords
injectable biomaterials
biomaterials
injectable
Prior art date
Application number
HUE19182834A
Other languages
English (en)
Inventor
Anthony Steven Weiss
Suzanne Marie Mithieux
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901028A external-priority patent/AU2009901028A0/en
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Publication of HUE053947T2 publication Critical patent/HUE053947T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
HUE19182834A 2009-03-10 2010-03-10 Injektálható bioanyagok HUE053947T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2009901028A AU2009901028A0 (en) 2009-03-10 Injectable biomaterials

Publications (1)

Publication Number Publication Date
HUE053947T2 true HUE053947T2 (hu) 2021-08-30

Family

ID=42727703

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE19182834A HUE053947T2 (hu) 2009-03-10 2010-03-10 Injektálható bioanyagok
HUE10750240A HUE047235T2 (hu) 2009-03-10 2010-03-10 Befecskendezhetõ biológiai anyagok

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE10750240A HUE047235T2 (hu) 2009-03-10 2010-03-10 Befecskendezhetõ biológiai anyagok

Country Status (13)

Country Link
US (1) US8974803B2 (hu)
EP (3) EP3566713B1 (hu)
JP (1) JP5684154B2 (hu)
KR (1) KR101708622B1 (hu)
CN (1) CN102348464B (hu)
AU (1) AU2010223851B2 (hu)
BR (1) BRPI1009422B1 (hu)
CA (1) CA2787849C (hu)
DK (2) DK3566713T3 (hu)
ES (2) ES2871977T3 (hu)
HU (2) HUE053947T2 (hu)
PL (1) PL3566713T3 (hu)
WO (1) WO2010102337A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365746A (ja) * 1989-08-04 1991-03-20 Nec Corp 入出力制御装置
CN102348464B (zh) 2009-03-10 2016-05-25 悉尼大学 可注射生物材料
SG177615A1 (en) * 2009-07-10 2012-03-29 Dow Global Technologies Llc Core/shell rubbers for use in electrical laminate compositions
DK2760466T3 (da) * 2011-09-30 2019-06-17 Allergan Pharmaceuticals Int Ltd In-vivo-syntese af elastisk fiber
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
CN105246520B (zh) 2012-12-10 2017-11-21 埃拉斯塔根私人有限公司 可缩放的三维弹性构建体制造
BR112016003082A8 (pt) * 2013-08-13 2020-01-28 Elastagen Pty Ltd uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida
ITMI20131927A1 (it) 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection. emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
DE102015207843B4 (de) 2015-04-28 2018-06-07 Duesenfeld Gmbh Verfahren zum Behandeln gebrauchter Batterien und Batterie-Verarbeitungsanlage
AU2016314775A1 (en) 2015-09-01 2018-03-22 Allergan Pharmaceuticals International Limited Formation of bone
US10899667B2 (en) * 2017-05-26 2021-01-26 Clemson University Covalently cross-linked lignocellulosic composites and applications thereof
CN107376024B (zh) * 2017-06-29 2021-03-16 成都清科生物科技有限公司 一种用于治疗女性压力性尿失禁的注射制剂及注射方法
BR112022003367A2 (pt) * 2019-08-23 2022-05-17 Allergan Pharmaceuticals Int Ltd Tropoelastina para uso em tratamento de cicatrizes de acne

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232458B1 (en) 1992-12-22 2001-05-15 The University Of Sydney Synthetic polynucleotides encoding tropoelastin
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
CA2262446A1 (en) 1996-08-07 1998-02-12 Protein Specialties, Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7193043B1 (en) 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
CA2383539C (en) 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
WO2001036000A1 (en) 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20050244393A1 (en) * 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
WO2002096978A1 (fr) 2001-05-30 2002-12-05 Keiichi Miyamoto Elastine reticulee et son procede de production
US7641643B2 (en) * 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8226715B2 (en) * 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
WO2007048115A2 (en) 2005-10-19 2007-04-26 Gregory Kenton W Method of using and producing tropoelastin and tropoelastin biomaterials
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
US8101717B2 (en) 2006-11-13 2012-01-24 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
CN102348464B (zh) 2009-03-10 2016-05-25 悉尼大学 可注射生物材料
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof

Also Published As

Publication number Publication date
JP2012519713A (ja) 2012-08-30
KR101708622B1 (ko) 2017-02-21
CA2787849A1 (en) 2010-09-16
DK2405936T3 (da) 2019-11-04
BRPI1009422B1 (pt) 2019-10-01
ES2755902T3 (es) 2020-04-24
PL3566713T3 (pl) 2021-12-06
AU2010223851B2 (en) 2017-03-16
JP5684154B2 (ja) 2015-03-11
HUE047235T2 (hu) 2020-04-28
AU2010223851A1 (en) 2011-09-22
EP2405936B1 (en) 2019-08-21
ES2871977T3 (es) 2021-11-02
CA2787849C (en) 2018-03-06
US8974803B2 (en) 2015-03-10
KR20110127746A (ko) 2011-11-25
CN102348464A (zh) 2012-02-08
DK3566713T3 (da) 2021-04-06
EP3566713B1 (en) 2021-03-03
BRPI1009422A2 (pt) 2016-03-01
EP3566713A1 (en) 2019-11-13
CN102348464B (zh) 2016-05-25
EP2405936A4 (en) 2012-12-19
EP3881825A1 (en) 2021-09-22
US20120003283A1 (en) 2012-01-05
WO2010102337A1 (en) 2010-09-16
EP2405936A1 (en) 2012-01-18

Similar Documents

Publication Publication Date Title
HUE047235T2 (hu) Befecskendezhetõ biológiai anyagok
GB201002407D0 (en) Electic machine - flux
IL219073A0 (en) Combination
GB0900269D0 (en) Silicate-substituted hydroxyapatite
GB2476400B (en) Syringes
IL219103A0 (en) Combination
IL219786A0 (en) Combination
IL218999A0 (en) Combination
IL218797A0 (en) Combination
HK1140909A2 (en) Show off
IL218846A0 (en) Combination
IL219000A0 (en) Combination
IL218801A0 (en) Combination
AU2009901028A0 (en) Injectable biomaterials
GB0820320D0 (en) Biomaterials
GB201014136D0 (en) Biomaterial
IL199679A0 (en) Injectable pharmaceutical composition
GB0906555D0 (en) Tolerance
GB0921939D0 (en) Syringes
AU328248S (en) Oven
GB0913322D0 (en) Xxxx
GB0906696D0 (en) Combination
GB0901391D0 (en) Combination